AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022
Standard
AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022. / Banys-Paluchowski, Maggie; Thill, Marc; Kühn, Thorsten; Ditsch, Nina; Heil, Jörg; Wöckel, Achim; Fallenberg, Eva; Friedrich, Michael; Kümmel, Sherko; Müller, Volkmar; Janni, Wolfgang; Albert, Ute-Susann; Bauerfeind, Ingo; Blohmer, Jens-Uwe; Budach, Wilfried; Dall, Peter; Fasching, Peter; Fehm, Tanja; Gluz, Oleg; Harbeck, Nadia; Huober, Jens; Jackisch, Christian; Kolberg-Liedtke, Cornelia; Kreipe, Hans H; Krug, David; Loibl, Sibylle; Lüftner, Diana; Lux, Michael Patrick; Maass, Nicolai; Mundhenke, Christoph; Nitz, Ulrike; Park-Simon, Tjoung Won; Reimer, Toralf; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schütz, Florian; Sinn, H Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Untch, Michael; Witzel, Isabell; Gerber, Bernd.
in: GEBURTSH FRAUENHEILK, Jahrgang 82, Nr. 10, 10.2022, S. 1031-1043.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022
AU - Banys-Paluchowski, Maggie
AU - Thill, Marc
AU - Kühn, Thorsten
AU - Ditsch, Nina
AU - Heil, Jörg
AU - Wöckel, Achim
AU - Fallenberg, Eva
AU - Friedrich, Michael
AU - Kümmel, Sherko
AU - Müller, Volkmar
AU - Janni, Wolfgang
AU - Albert, Ute-Susann
AU - Bauerfeind, Ingo
AU - Blohmer, Jens-Uwe
AU - Budach, Wilfried
AU - Dall, Peter
AU - Fasching, Peter
AU - Fehm, Tanja
AU - Gluz, Oleg
AU - Harbeck, Nadia
AU - Huober, Jens
AU - Jackisch, Christian
AU - Kolberg-Liedtke, Cornelia
AU - Kreipe, Hans H
AU - Krug, David
AU - Loibl, Sibylle
AU - Lüftner, Diana
AU - Lux, Michael Patrick
AU - Maass, Nicolai
AU - Mundhenke, Christoph
AU - Nitz, Ulrike
AU - Park-Simon, Tjoung Won
AU - Reimer, Toralf
AU - Rhiem, Kerstin
AU - Rody, Achim
AU - Schmidt, Marcus
AU - Schneeweiss, Andreas
AU - Schütz, Florian
AU - Sinn, H Peter
AU - Solbach, Christine
AU - Solomayer, Erich-Franz
AU - Stickeler, Elmar
AU - Thomssen, Christoph
AU - Untch, Michael
AU - Witzel, Isabell
AU - Gerber, Bernd
N1 - The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).
PY - 2022/10
Y1 - 2022/10
N2 - The recommendations of the AGO Breast Committee on the surgical therapy of breast cancer were last updated in March 2022 (www.ago-online.de). Since surgical therapy is one of several partial steps in the treatment of breast cancer, extensive diagnostic and oncological expertise of a breast surgeon and good interdisciplinary cooperation with diagnostic radiologists is of great importance. The most important changes concern localization techniques, resection margins, axillary management in the neoadjuvant setting and the evaluation of the meshes in reconstructive surgery. Based on meta-analyses of randomized studies, the level of recommendation of an intraoperative breast ultrasound for the localization of non-palpable lesions was elevated to "++". Thus, the technique is considered to be equivalent to wire localization, provided that it is a lesion which can be well represented by sonography, the surgeon has extensive experience in breast ultrasound and has access to a suitable ultrasound device during the operation. In invasive breast cancer, the aim is to reach negative resection margins ("no tumor on ink"), regardless of whether an extensive intraductal component is present or not. Oncoplastic operations can also replace a mastectomy in selected cases due to the large number of existing techniques, and are equivalent to segmental resection in terms of oncological safety at comparable rates of complications. Sentinel node excision is recommended for patients with cN0 status receiving neoadjuvant chemotherapy after completion of chemotherapy. Minimally invasive biopsy is recommended for initially suspect lymph nodes. After neoadjuvant chemotherapy, patients with initially 1 - 3 suspicious lymph nodes and a good response (ycN0) can receive the targeted axillary dissection and the axillary dissection as equivalent options.
AB - The recommendations of the AGO Breast Committee on the surgical therapy of breast cancer were last updated in March 2022 (www.ago-online.de). Since surgical therapy is one of several partial steps in the treatment of breast cancer, extensive diagnostic and oncological expertise of a breast surgeon and good interdisciplinary cooperation with diagnostic radiologists is of great importance. The most important changes concern localization techniques, resection margins, axillary management in the neoadjuvant setting and the evaluation of the meshes in reconstructive surgery. Based on meta-analyses of randomized studies, the level of recommendation of an intraoperative breast ultrasound for the localization of non-palpable lesions was elevated to "++". Thus, the technique is considered to be equivalent to wire localization, provided that it is a lesion which can be well represented by sonography, the surgeon has extensive experience in breast ultrasound and has access to a suitable ultrasound device during the operation. In invasive breast cancer, the aim is to reach negative resection margins ("no tumor on ink"), regardless of whether an extensive intraductal component is present or not. Oncoplastic operations can also replace a mastectomy in selected cases due to the large number of existing techniques, and are equivalent to segmental resection in terms of oncological safety at comparable rates of complications. Sentinel node excision is recommended for patients with cN0 status receiving neoadjuvant chemotherapy after completion of chemotherapy. Minimally invasive biopsy is recommended for initially suspect lymph nodes. After neoadjuvant chemotherapy, patients with initially 1 - 3 suspicious lymph nodes and a good response (ycN0) can receive the targeted axillary dissection and the axillary dissection as equivalent options.
U2 - 10.1055/a-1904-6231
DO - 10.1055/a-1904-6231
M3 - SCORING: Journal article
C2 - 36186147
VL - 82
SP - 1031
EP - 1043
JO - GEBURTSH FRAUENHEILK
JF - GEBURTSH FRAUENHEILK
SN - 0016-5751
IS - 10
ER -